P
Peter F Rebeiro
Researcher at Vanderbilt University Medical Center
Publications - 18
Citations - 333
Peter F Rebeiro is an academic researcher from Vanderbilt University Medical Center. The author has contributed to research in topics: Population & Raltegravir. The author has an hindex of 6, co-authored 18 publications receiving 117 citations. Previous affiliations of Peter F Rebeiro include Vanderbilt University.
Papers
More filters
Journal ArticleDOI
Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada.
Kassem Bourgi,Kassem Bourgi,Cathy A. Jenkins,Peter F Rebeiro,Frank J. Palella,Richard D. Moore,Keri N Altoff,John Gill,Charles S. Rabkin,Stephen J. Gange,Michael A. Horberg,Joseph B. Margolick,Jun Li,Cherise Wong,Amanda L. Willig,Viviane D. Lima,Heidi M. Crane,Jennifer E. Thorne,Michael J. Silverberg,Gregory D. Kirk,William C. Mathews,Timothy R. Sterling,Jordan E. Lake,John R. Koethe,John R. Koethe +24 more
TL;DR: Relationships between ART drug class and weight change among treatment‐naïve PWH initiating ART in the North American AIDS Cohort Collaboration on Research and Design (NA‐ACCORD) are assessed.
Journal ArticleDOI
Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study
Raúl U. Hernández-Ramírez,Li Qin,Haiqun Lin,Wendy A. Leyden,Romain Neugebauer,Keri N. Althoff,Chad J. Achenbach,Nancy A. Hessol,Gypsyamber D'Souza,Kelly A. Gebo,M. John Gill,Surbhi Grover,Michael A. Horberg,Jun Li,W. Christopher Mathews,Angel M. Mayor,Lesley S. Park,Charles S. Rabkin,Kate Salters,Amy C. Justice,Amy C. Justice,Richard D. Moore,Eric A. Engels,Michael J. Silverberg,Robert Dubrow,Adrian Betts,John T. Brooks,Aimee M. Freeman,Stephen E. Van Rompaey,Ann N. Burchell,Benita Yip,Bin You,Brenna C. Hogan,Chris Grasso,Robert S. Hogg,Constance A. Benson,Daniel R. Drozd,Timothy R. Sterling,David W. Haas,Elizabeth Humes,Heidi M. Crane,James H. Willig,Joseph J. Eron,Jeffrey N. Martin,Michael S. Saag,Jerry Jing,Jinbing Zhang,Joanne Lindsay,Robert F. Hunter-Mellado,Steven G. Deeks,Julia Zhu,Julio S. G. Montaner,Justin McReynolds,Karyn Gabler,Kate Buchacz,Benigno Rodriguez,Jennifer E. Thorne,Joseph B. Margolick,Kathryn Anastos,Lisa P. Jacobson,Marina B. Klein,Abigail Kroch,Liz Morton,Megan Turner,David A. Fiellin,Stephen J. Gange,Michael J. Mugavero,P. Richard Harrigan,Peter F Rebeiro,Ronald J. Bosch,Gregory D. Kirk,Kenneth H. Mayer,Rosemary G. McKaig,Sally Coburn,Sonia Napravnik,Mari M. Kitahata,William B. Lober,Jennifer S. Lee +77 more
TL;DR: Both recent immunosuppression and prolonged HIV viraemia have important independent roles in the development of non-Hodgkin lymphoma, with likely subtype heterogeneity.
Journal ArticleDOI
Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens.
Michael Leonard,Zinhle Cindi,Yuki Bradford,Kassem Bourgi,John R. Koethe,Megan Turner,Jamison Norwood,Beverly O. Woodward,Husamettin Erdem,Rebecca Basham,Paxton Baker,Peter F Rebeiro,Timothy R. Sterling,Todd Hulgan,Eric S. Daar,Roy M. Gulick,Sharon A. Riddler,Phumla Sinxadi,Marylyn D. Ritchie,David W Haas,David W Haas +20 more
TL;DR: Among patients who switched from efavirenz- to INSTI-based therapy, CYP2B6 genotype was associated with weight gain, possibly reflecting withdrawal of the inhibitory effect of higher efvirenz concentrations on weight gain.
Journal ArticleDOI
Systematic review of prediction models for pulmonary tuberculosis treatment outcomes in adults.
Lauren S Peetluk,Felipe Ridolfi,Peter F Rebeiro,Dandan Liu,Valeria Cavalcanti Rolla,Timothy R Sterling +5 more
TL;DR: A systematic review and evaluation of prediction models developed to predict tuberculosis (TB) treatment outcomes among adults with pulmonary TB was conducted in this article, where the most common predictors included age, sex, extrapulmonary TB, body mass index, chest X-ray results, previous TB and HIV.
Journal ArticleDOI
Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study.
Casey L Smiley,Peter F Rebeiro,Carina Cesar,Pablo F. Belaunzarán-Zamudio,Brenda Crabtree-Ramírez,Denis Padgett,Eduardo Gotuzzo,Claudia P. Cortes,Jean W. Pape,Valdilea G. Veloso,Catherine C. McGowan,Jessica L Castilho,Central Caribbean +12 more
TL;DR: Persistent disparities in life expectancy among people with HIV by demographic and clinical factors at ART initiation highlight vulnerable populations in the region.